Semaglutide Longevity: 2026 Lifespan Research, Cognition Data, and Prices

Short answer: why this research matters

Semaglutide longevity research now includes longer survival in aged female mice and an observational human cognition signal. The useful semaglutide longevity question is what each study measured, then how to compare the exact product, documented content, vendor proof, and price on PeptidePub.

The headline number is concrete: median lifespan was 834 days with semaglutide versus 742 days in controls. That is 92 additional days, a 12.4% relative increase in total median lifespan, not remaining lifespan. It is a mouse result, not proof of human lifespan extension or a human anti-aging dose.

This guide separates that survival finding from human cognition records and the prices buyers actually encounter. For broader cardiac, liver, and brain context, see GLP-1 benefits beyond weight loss. For comparisons with Epitalon, MOTS-c, NAD+, and SS-31, use our longevity peptide guide.

Here, the practical question is narrower: what makes semaglutide interesting in 2026, and what evidence should sit beside a price before you pay?

What the Nature mouse study tested

The Nature paper, DOI 10.1038/s41586-026-10940-7, started female C57BL/6 mice at 20 months old. The lifespan cohort received treatment for the duration of life. Separate physiology and molecular cohorts received treatment for 3 months. Those timelines matter: the survival result was not simply a three-month intervention.

Alongside the 742-to-834-day median survival difference, food intake fell 24%. The researchers reported improvements in Barnes maze cognition, rotarod motor performance, inverted-screen muscle function, treadmill exhaustion, and glucose tolerance. Together, these findings connect survival with several measures of late-life function rather than body weight alone.

The paper also examined stem-cell attrition, inflammation, cellular senescence, mitochondrial dysfunction, loss of proteostasis, and genomic instability. Those are experimental mouse endpoints, not six clinically reversed hallmarks of aging in people.

The useful takeaway is the breadth of the signal: survival, physical performance, cognition, and molecular measurements moved in promising directions within this experiment. It does not supply a mouse-to-human dose conversion, a veterinary application, or evidence that a retail vial reproduces the studied material. Keep the experiment's population and treatment duration attached to its headline number.

Human cognition: what the records show

The BMJ Mental Health study (2026;29:e302828, PMID 42624612) used retrospective NeuroBlu US psychiatric-care records spanning 1999-2024. There were 13,007 eligible adults, including 1,261 who initiated semaglutide. Mean age was 62.0 years, standard deviation 13.4; 6,300 participants were female, or 48.4%.

Researchers modeled outcomes over 12 months using a cognitive signs/symptoms score from 0 to 100. Lower meant fewer recorded problems involving memory, attention, orientation, and other cognitive functions. It was not an intelligence score.

The modeled mean scores and semaglutide-to-comparator mean ratios were:

• Semaglutide: 11.14, the reference strategy.
• No treatment: 14.91; MR 0.75, 95% CI 0.65-0.85.
• Glipizide: 13.46; MR 0.83, 95% CI 0.70-0.93.
• Empagliflozin: 13.69; MR 0.81, 95% CI 0.69-0.94.
• Sitagliptin: 12.52; MR 0.89, 95% CI 0.77-1.02. This difference was not statistically significant.

Read those ratios in the correct direction: semaglutide divided by each comparator. An MR of 0.75 describes the modeled symptom-score comparison. It does not mean 25% less dementia or 25% better memory. Keeping the nonsignificant sitagliptin comparison visible gives a more complete picture than quoting only the strongest contrast.

Why the cognition signal is not a treatment promise

The study used a parametric g-formula to estimate sustained-treatment strategies. That is different from observing confirmed adherence for a full year. Baseline dementia was excluded, and the exploratory no-treatment comparison came from people stopping antidiabetic medication, not never-treated healthy controls.

Residual confounding, routine electronic-record assessments, and unconfirmed adherence limit causal interpretation. The result is an interesting association worth following, not a randomized demonstration of memory treatment, dementia prevention, or longer human life.

For buyers, that distinction makes the evidence more useful. A mouse survival curve answers a different question from a modeled human symptom score. Neither authenticates the contents of a seller's vial. Product documentation needs its own check, independent of how exciting the compound's research looks.

Use the semaglutide guide for compound context, then compare the category you actually intend to purchase. Finished medicines, compounded formulations, and laboratory material should not share a single price ranking. A research-vial price per mg and a clinician-managed monthly service describe different products and costs.

Research-vial prices: compare like with like

These USD seller-page examples were checked November 4, 2026, before tax and delivery. They are not a whole-market cheapest-vendor ranking.

• LabFirst 10 mg: $70, or $7.00 per labeled mg; in stock.
• LabFirst 30 mg: $115, or $3.83 per labeled mg; in stock.
• Reserve Research 10 mg: $50, or $5.00 per labeled mg.

LabFirst also displayed backordered sizes: 5 mg for $55 ($11/mg), 15 mg for $105 ($7/mg), and 20 mg for $110 ($5.50/mg). A listed price is not the same as available inventory.

LabFirst's 30 mg option was 45.24% cheaper per labeled mg than its 10 mg option, about 45% rounded. That is unit pricing, not a reason to order unnecessary quantity.

Reserve listed $10 two-day shipping and free shipping on $100+ before discounts. One $50 vial plus $10 shipping gives an illustrative $60 total, or $6.00 per labeled mg, before applicable taxes or fees. Checkout was not verified. LabFirst advertised free shipping over $150; its single-vial delivery charge was not verified.

Compare current semaglutide prices, then use the cost-per-dose tool for relevant arithmetic, not an anti-aging regimen. The denominator matters: delivered cost divided by documented active mg, explicitly labeled as label-based or independently measured.

COA evidence: what the sellers report

LabFirst's page reported 10 mg lot LF-23B-2609 at 99.656% HPLC purity and 30 mg lot LF-23E-2609 at 99.789%. It listed LC-MS identity, an October 7, 2026 test date, endotoxin and sterility passes, and fentanyl not detected. The seller said only 2 of 5 sizes had published Kovera certificates, with the others in testing.

Reserve identified current shipping lot SEM010-001 and reported 99.594% purity, measured content of 12.71 mg, and an endotoxin pass. Its page linked a Kovera verification record. That does not establish sterility testing.

These are seller statements; the linked lab reports were not independently authenticated for this guide. Reserve's reported 12.71 mg therefore does not replace the labeled 10 mg in our price arithmetic. Nor should a result for one lot be transferred to every vial or another size.

Ask for the exact compound and formulation, shipping lot, report ID, and named-lab verification. Then inspect identity and quantitative net content, followed separately by sterility and endotoxin results where relevant. HPLC purity alone establishes neither fill weight, clinical equivalence, nor suitability for administration.

Our COA reading guide, vendor directory, and methodology help turn those questions into a consistent comparison.

Deals: read the conditions before calculating savings

LabFirst displayed 10% off 10-19 vials and 15% off 20 vials per size. Its monthly subscription offered 6% off starting with shipment 2, with a two-shipment minimum. That is not a first-order 6% discount.

Reserve advertised 30% off complete same-size 10-vial kits, without coupon stacking. The extracted kit total was blank, so there is no confirmed kit price to quote. Do not turn a percentage banner into a supposedly verified checkout total.

Neither chemical seller is a PeptidePub affiliate in this comparison. The listed offers are seller-page terms, not authenticated coupon codes or a recommendation to buy in bulk.

The best deal is the eligible offer on the amount and product you need, with documentation you can match to the shipment. Compare the payable total rather than the largest advertised percentage. Minimum quantities, shipping thresholds, recurring commitments, and stacking restrictions can change the result.

Check current deals before checkout. Save the relevant offer terms with the lot report so you can distinguish what was advertised from what your order actually received.

Choose the right purchasing path

For clinician-managed semaglutide for an appropriate metabolic indication, our SkinnyRx review covers a separate care pathway. It is not an anti-aging or cognition-treatment recommendation, and the review's historical pricing is not a fresh monthly quote.

Do not compare that service directly with the $50 or $70 research-vial examples. Care services, finished medicines, compounded formulations, and laboratory materials differ in what the purchase includes. The longevity paper does not endorse a retailer or establish equivalent efficacy across those categories.

Start with the category, then compare the documented product and complete cost. PeptidePub's price comparisons help organize the buying decision; the product evidence still needs to match the exact offer.

FAQ

Does semaglutide extend lifespan?

In the specific female-mouse experiment, median lifespan increased from 742 to 834 days. These studies do not establish human lifespan extension.

Does semaglutide improve memory?

The human records study found lower modeled cognitive signs/symptoms scores versus several comparators, but not a significant difference versus sitagliptin. That is association, not a randomized memory-treatment result.

What is a semaglutide longevity dose?

These studies establish no human anti-aging regimen. Animal experimental exposure and consumer anecdotes do not supply one.

How should I compare semaglutide prices?

Compare the same category and documented amount. The observed 10 mg research examples were $50 and $70 before delivery; LabFirst's 30 mg example was $115. Check the shipping lot, availability, delivery cost, and deal restrictions alongside the unit price. Use labeled mg unless independently authenticated quantitative evidence supports a different denominator.

Bottom line: interesting evidence, concrete buying checks

The 2026 longevity and cognition findings make semaglutide worth understanding beyond weight loss. Keep mouse survival, modeled human symptom scores, and actual product proof in separate columns. Each contributes something useful; none substitutes for the others.

Before paying, compare the right product category, confirm the shipment's documentation, and calculate the complete cost. Start with semaglutide prices, check vendor evidence, and review eligible deals. Make PeptidePub the check before checkout, with the research understood and the numbers attached to the offer you actually intend to buy.